DE4140474A1 - Glycerin monoalkyl ether used as skincare additives in cosmetic compsn. - prevents drying of skin, regulates moisture content and gives pleasant feel - Google Patents
Glycerin monoalkyl ether used as skincare additives in cosmetic compsn. - prevents drying of skin, regulates moisture content and gives pleasant feelInfo
- Publication number
- DE4140474A1 DE4140474A1 DE19914140474 DE4140474A DE4140474A1 DE 4140474 A1 DE4140474 A1 DE 4140474A1 DE 19914140474 DE19914140474 DE 19914140474 DE 4140474 A DE4140474 A DE 4140474A DE 4140474 A1 DE4140474 A1 DE 4140474A1
- Authority
- DE
- Germany
- Prior art keywords
- cleaning
- skin
- care
- use according
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/72—Ethers of polyoxyalkylene glycols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/002—Aftershave preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Abstract
Description
Die Erfindung betrifft Verbindungen, die als Hautpflegeadditiv in Reinigungs- und Pflegeprodukten insbesondere aus dem kosme tiknahen und dem kosmetischen Bereich eingesetzt werden können.The invention relates to compounds useful as a skin care additive in cleaning and care products especially from the kosme tiknahen and the cosmetic field can be used.
Veränderte Lebensgewohnheiten verbunden mit einem gestiegenen Hygienebewußtsein haben in jüngerer Zeit zur vermehrten Anwendung von kosmetischen Reinigungs- und Pflegeprodukten, wie z. B. Seifen, Dusch- und Badepräparaten geführt. Je häufiger derartige seifen- bzw. tensidhaltige Produkte auf der Haut angewandt werden, desto deutlicher treten deren nachteilige Wirkungen, nämlich die Entfettung und Austrocknung der Haut durch die Zerstörung des Hydro-Lipid-Mantels, in den Vordergrund.Changing lifestyles associated with a risen Hygiene awareness has recently become more widespread of cosmetic cleaning and care products, such. B. Soaps, shower and bathing preparations. The more common such soap or surfactant-containing products applied to the skin the more obvious are their adverse effects, namely the degreasing and dehydration of the skin through the Destruction of the hydro-lipid coat, in the foreground.
Für eine optimale dermatologische Verträglichkeit derartiger Produkte sind daher pflegende Zusätze mit rückfettenden und feuchtigkeitsspendenden Eigenschaften notwendig.For optimal dermatological compatibility of such Products are therefore caring additives with moisturizing and moisturizing properties necessary.
Nach Anwendung der oben erwähnten Reinigungs- und Pflegeprodukte sorgen Emulsionen des o/w- (Öl in Wasser) oder w/o- (Wasser in Öl) Typs für eine Regulierung des Lipid- und Feuchtigkeits haushalts der Haut. Auch für diese Produkte ist eine sorgfältige Auswahl der Lipid-Komponenten und weiterer pflegender Zusätze, abgestimmt auf bestimmte Hauttypen, erforderlich.After applying the above-mentioned cleaning and care products Ensure emulsions of o / w (oil in water) or w / o (water in Oil) type for regulation of lipid and moisture Household of the skin. Also for these products is a careful Selection of lipid components and other care additives, matched to certain skin types, required.
Der Erfindung liegt die Aufgabe zugrunde, insbesondere kosmeti sche, ein geeignetes Hautpflegeadditiv enthaltende Reinigungs- und Pflegeprodukte zur Verfügung zu stellen, bei denen das Hautpflegeadditiv selbst bei häufiger Produktanwendung ein Austrocknen der Haut verhindert und den Feuchtigkeitsgehalt reguliert, gleichzeitig aber die Haut in ausreichendem Ausmaß rückfettet und darüber hinaus auch noch ein angenehmes Hautgefühl vermittelt.The invention is based on the object, in particular cosmeti containing a suitable skin care additive To provide cleaning and care products in which the Skin care additive even with frequent product use Drying of the skin prevents and the moisture content regulates, but at the same time the skin sufficiently Greases and also a pleasant skin feeling taught.
Diese Aufgabe wird dadurch gelöst, daß als Hautpflegeadditiv Glycerinmonoalkylether verwendet werden.This object is achieved in that as skin care additive Glycerol monoalkyl ethers are used.
Bevorzugte Ausführungsformen der Erfindung sind Gegenstand der Unteransprüche.Preferred embodiments of the invention are the subject of Dependent claims.
Die erfindungsgemäß verwendeten Glycerinmonoalkylether besitzen die allgemeine FormelThe glycerol monoalkyl ethers used according to the invention have the general formula
in der R ein gerad- oder verzweigtkettiger Alkylrest mit 3 bis 14, insbesondere 5 bis 12 und vorzugsweise 7 bis 12 Kohlenstoff atomen ist. Hierzu gehören beispielsweise 1-Heptylglycerinether, 1-(2-Ethylhexyl)glycerinether, 1-Octylglycerinether, 1-Decyl glycerinetherund 1-Dodecylglycerinether, wobei 1-(2-Ethylhexyl) glycerinether besonders bevorzugt ist. Diese Verbindungen sind leicht zugänglich. Ihre Herstellung ist in der Literatur beschrieben, z. B. in JP 80-19 253, JP 58-1 34 049, DE 33 43 530 und E. Baer, H.O.L. Fischer in J. Biol. Chem. 140 397 (1941).in the R a straight or branched chain alkyl radical with 3 bis 14, in particular 5 to 12 and preferably 7 to 12 carbon is atoms. These include, for example, 1-heptylglycerol ether, 1- (2-ethylhexyl) glycerol ether, 1-octyl glycerol ether, 1-decyl glycerol ether and 1-dodecylglycerol ether, wherein 1- (2-ethylhexyl) glycerol ether is particularly preferred. These connections are easy to access. Their production is in the literature described, for. In JP 80-19 253, JP 58-1 34 049, DE 33 43 530 and E. Baer, H.O.L. Fischer in J. Biol. Chem. 140, 397 (1941).
Die erfindungsgemäß eingesetzten Glycerinether können ins besondere als Hautpflegeadditiv für Produkte aus dem kosmetischen und kosmetiknahen Bereich verwendet werden. Hierzu gehören z . B. Reinigungs- und Pflegeprodukte wie feste oder flüssige Seifen, Duschbäder, Duschgele, Schaumbäder, Shampoos, Waschlotionen, Tagescremes, Pflegecremes, Pflegeemulsionen, Aftershave-Lösungen bzw. -emulsionen und Handgeschirrspülmittel.The glycerol ethers used in the invention can in Special as skin care additive for products from the cosmetic and cosmetics-related area. These include z. B. Cleaning and care products such as solid or liquid soaps, Shower baths, shower gels, bubble baths, shampoos, washing lotions, Day creams, care creams, care emulsions, aftershave solutions or emulsions and hand dishwashing detergents.
Im allgemeinen kommen für derartige Systeme nur hinreichend hydrophile Lipid-Komponenten als Rückfetter in Frage, weil stärker lipophile Substanzen wie Öle und Fette in derartigen Systemen eine zu geringe Löslichkeit aufweisen.In general, such systems are only adequate hydrophilic lipid components as a moisturizer in question, because more lipophilic substances such as oils and fats in such Systems have too low a solubility.
Nachdem die Alkanolamide wegen der Nitrosamin-Problematik weniger gern eingesetzt werden, werden als hydrophile Rückfetter für tensidhaltige Produkte u. a. ethoxylierte Alkohole sowie ethoxy lierte Mono-, Diglyceride und Triglyceride verwendet.After the alkanolamides because of the nitrosamine problem less like to be used as a hydrophilic moisturizer for surfactant-containing products u. a. ethoxylated alcohols and ethoxy lated mono-, diglycerides and triglycerides used.
Die erfindungsgemäß verwendeten Glycerinmonoalkylether nehmen aufgrund ihres ambiphilen Charakters ähnlich wie die Monoglyceri de eine Mittelstellung bezüglich der Hydrophilie/Lipophilie zwischen den oben erwähnten hydrophilen Komponenten und den reinen Fetten ein.Take the glycerol monoalkyl ethers used in the invention because of their ambiphilic character similar to the monoglyceri de an intermediate position with respect to the hydrophilicity / lipophilicity between the above-mentioned hydrophilic components and the pure fats.
Daraus resultiert, daß insbesondere die Glycerinmonoalkylether, bei denen der Alkylrest 8 bis 14, insbesondere 8 bis 12 Kohlen stoffatome enthält, in tensidhaltigen Produkten eine ausgeprägte rückfettende Wirkung zeigen, die nach der Anwendung zu einem an genehmen Hautgefühl führt. In den erforderlichen Einsatzkonzen trationen besitzen die genannten Glycerinmonoalkylether in den Zielprodukten eine gute Löslichkeit.As a result, in particular the glycerol monoalkyl ethers, in which the alkyl radical 8 to 14, in particular 8 to 12 carbon atoms contains, in surfactant-containing products a pronounced moisturizing effect, which after the application to a feels good. In the required operational plans The mentioned glycerol monoalkyl ethers have the abovementioned Target products have good solubility.
Darüber hinaus kommt den erfindungsgemäß verwendeten Additiven als weitere hautpflegende Eigenschaft ein gewisses Feuchthalte vermögen zu. Dieser Effekt ist bei den kürzerkettigen Derivaten, bei denen R ein Alkylrest mit 3 bis 8, insbesondere 5 bis 8 Kohlenstoffatomen ist, besonders ausgeprägt. In addition, the additives used in the invention comes as a further skin care property a certain moisturizing properties able to. This effect is with the shorter-chain derivatives, in which R is an alkyl radical having 3 to 8, in particular 5 to 8 Carbon atoms is, especially pronounced.
Bei den erfindungsgemäß eingesetzten Glycerinethern handelt es sich um in chemisch reiner Form herstellbare farb- und geruchs neutrale Verbindungen. Derivate mit einem Alkylrest mit bis zu 9 Kohlenstoffatomen sind bei Raumtemperatur flüssig und lassen sich daher besonders leicht in die Produkte einarbeiten.The glycerol ethers used according to the invention are to be produced in chemically pure form color and smell neutral connections. Derivatives with an alkyl radical with up to 9 carbon atoms are liquid at room temperature and leave Therefore, it is particularly easy to work into the products.
Von besonderem Vorteil ist die im Vergleich zu Fettsäureestern, z. B. Mono- und Diglyceriden, größere chemische Stabilität der Glycerinmonoalkylether. Bedingt durch ihre Etherstruktur sind die erfindungsgemäßen Hautpflegeadditive auch im alkalischen Bereich einsetzbar. Dies ist besonders vorteilhaft für den Einsatz in flüssigen Seifen, wo es bei hohen pH-Werten und großem Wasser gehalt zur Hydrolyse der Glyceride unter Freisetzung von Fett säuren kommt, was sich u. a. in einer schlechten Kältestabilität der entsprechenden Produkte äußert. Auch eine enzymatische Spal tung unter Freisetzung von Fettsäuren, die bei den Glyceriden auftreten kann, ist bei den Glycerinmonoalkylethern nicht zu befürchten.Of particular advantage compared to fatty acid esters, z. As mono- and diglycerides, greater chemical stability of Glycerol monoalkyl. Due to their ether structure are the Skincare additives according to the invention also in the alkaline range used. This is especially beneficial for use in liquid soaps, where it is at high pH and large water content to hydrolyze the glycerides to release fat acids, what u. a. in a bad cold stability corresponding products. Also an enzymatic spal under release of fatty acids, which in the glycerides can occur, is not in the Glycerinmonoalkylethern fear.
Die Einsatzkonzentration der Glycerinmonoalkylether liegt, bezogen auf das Produkt, im allgemeinen im Bereich von 0,01 bis 10 Gew.-%, bevorzugter 0,05 bis 5 Gew.-%. Wenn die Glycerin monoalkylether in erster Linie als Rückfetter in tensidhaltigen Formulierungen eingearbeitet sind, liegen sie vorzugsweise in einer Menge von 0,2 bis 5 Gew.-%, bevorzugter 0,5 bis 3 Gew.-% vor. Die Einsatzkonzentration richtet sich hierbei nach Art und Konzentration der waschaktiven Substanzen und der weiteren Additive sowie nach der Stärke des gewünschten rückfettenden Effekts.The use concentration of the glycerol monoalkyl ethers is based on the product, generally in the range of 0.01 to 10% by weight, more preferably 0.05 to 5% by weight. When the glycerin monoalkyl ethers primarily as backfat in surfactant-containing Formulations are incorporated, they are preferably in in an amount of 0.2 to 5% by weight, more preferably 0.5 to 3% by weight in front. The use concentration depends on the type and Concentration of the washing-active substances and the others Additives as well as according to the strength of the desired moisturizing Effect.
Neben der oben erwähnten Anwendung in Seifen oder tensidhaltigen Produkten kommen die erfindungsgemäßen Glycerinmonoalkylether auch als Lipid-Komponenten für o/w- oder w/o-Emulsionen wie Pflegecremes und -emulsionen in Betracht. Die Glycerinmono alkylether werden bei der Herstellung des jeweiligen Produkts der Fettphase vorzugsweise in einer Menge von 0,05 bis 5, bevorzugter 0,5 bis 3 Gew.-%, jeweils bezogen auf das Endprodukt zugegeben. Nach Anwendung der Emulsion verbleibt ein sehr angenehmes, glattes Hautgefühl.In addition to the above-mentioned application in soaps or surfactant-containing Products come Glycerinmonoalkylether invention also as lipid components for o / w or w / o emulsions such as Care creams and emulsions into consideration. The glycerol mono Alkyl ethers are used in the preparation of the respective product of Fat phase preferably in an amount of 0.05 to 5, more preferably 0.5 to 3 wt .-%, each based on the final product added. After application of the emulsion remains a very pleasant, smooth skin feeling.
Besonders vorteilhaft ist die Verwendung des erfindungsgemäßen Hautpflegeadditivs in Aftershave-Formulierungen. Hierunter fallen sowohl die viel Alkohol enthaltenden Produkte als auch die modernen Aftershave-Emulsionen. In diesen Produkten kommt die Funktion der Glycerinmonoalkylether als Lipid-Komponente und als feuchtigkeitsspendende Komponente besonders zur Geltung.Particularly advantageous is the use of the invention Skin care additives in aftershave formulations. Fall under this Both the much alcohol-containing products and the modern aftershave emulsions. In these products comes the Function of Glycerinmonoalkylether as a lipid component and as moisturizing component particularly to advantage.
Zur Demonstration der hautpflegenden Eigenschaften der Glycerin monoalkylether wurden folgende Testformulierungen gewählt.To demonstrate the skin-care properties of glycerin monoalkyl ethers, the following test formulations were selected.
A. Polyacrylatgel mit und ohne 1-(2-Ethylhexyl)glycerinetherA. Polyacrylate gel with and without 1- (2-ethylhexyl) glycerol ether
B. Waschlotion auf Seifenbasis mit und ohne 1-(2-Ethylhexyl) glycerinetherB. Soap-based washing lotion with and without 1- (2-ethylhexyl) glycerol ether
Es wurde ein Gel folgender Zusammensetzung hergestellt:A gel of the following composition was prepared:
In eine Teilmenge des Gels wurden 0,3 Gew.-% 1-(2-Ethylhexyl) glycerinether eingearbeitet. Beide Gele wurden in einem Anwen dungstest mit 10 Probanden auf der Handinnen- und -außenfläche im direkten Vergleich untersucht.In a subset of the gel was 0.3% by weight of 1- (2-ethylhexyl) incorporated glycerol ether. Both gels were in an application Training test with 10 subjects on the inside and outside of the hands examined in direct comparison.
Alle Probanden stellten einen deutlichen Unterschied zwischen den beiden Gelformulierungen fest. Das Gel mit dem Glycerinether hinterließ nach Anwendung ein deutlich spürbares angenehmes Hautgefühl, welches mit den AdjektivenAll subjects made a clear difference between the both gel formulations. The gel with the glycerol ether left a noticeable pleasant after application Skin sensation associated with the adjectives
- - samtig- velvety
- - glatt- smooth
- - geschmeidig- smooth
beschrieben wurde. Zum Hautgefühl nach Anwendung der Vergleichs formulierung ohne den Glycerinether wurden folgende Aussagen gemacht:has been described. To the skin feeling after application of the comparison Formulation without the glycerol ether were the following statements made:
- - trocken- dry
- - rauh- rough
- - stumpf.- dull.
Als besonders vorteilhaft wurde zusätzlich festgestellt, daß sich die Haut nach Applikation des glycerinetherhaltigen Gels weder fettig noch klebrig anfühlte.Particularly advantageous was also found that the skin neither after application of the glycerol ether-containing gel greasy or sticky.
Es wurde eine seifenhaltige Waschlotion folgender Zusammensetzung hergestellt:It was a soap-containing washing lotion the following composition manufactured:
In eine Teilmenge der Waschlotion wurden 2 Gew.-% 1-(2-Ethyl hexyl)glycerinether eingearbeitet. Dabei wurde ein geringer Viskositätsanstieg beobachtet. Mit einer Gruppe von sechs Probanden wurden Händewaschversuche mit der glycerinetherhaltigen und der glycerinetherfreien Waschlotion durchgeführt.In a subset of the washing lotion 2 wt .-% 1- (2-ethyl hexyl) glycerol ether incorporated. It was a small Viscosity increase observed. With a group of six Subjects were hand washing experiments with the glyceroletherhaltigen and the glycerol ether-free washing lotion performed.
Nach Anwendung der glycerinetherfreien Formulierung verblieb ein trockenes, stumpfes Hautgefühl. Die glycerinetherhaltige Formulierung hinterließ eine gepflegte, glatte, geschmeidige Haut. Das angenehme Hautgefühl hielt über mehrere Stunden an.After application of the glycerol ether-free formulation remained dry, dull skin feeling. The glycerinetherhaltige Formulation left a neat, smooth, supple Skin. The pleasant skin feeling lasted for several hours.
Die im folgenden aufgeführten weiteren Beispiele verdeutlichen die Einsatzmöglichkeiten der erfindungsgemäßen Glycerinether.The following examples illustrate the possible uses of the glycerol ethers according to the invention.
In sämtlichen genannten Beispielen wurden Glycerinmonoalkylether als Hautpflegeadditive eingesetzt. In all the examples mentioned, glycerol monoalkyl ethers used as skin care additives.
Ein Vergleich der folgenden Formulierungen A und B zeigt die überlegenen rückfettenden Eigenschaften der erfindungsgemäßen Glycerinmonoalkylether.A comparison of the following formulations A and B shows the superior refatting properties of the invention Glycerol monoalkyl.
Formulierung A
60% Ethanol
20% i-Propanol
1% Myristylalkohol
ad 100% WasserFormulation A
60% ethanol
20% i-propanol
1% myristyl alcohol
ad 100% water
Formulierung B
60% Ethanol
20% i-Propanol
1% Myristylalkohol
1% 1-(2-Ethylhexyl)glycerinether
ad 100% WasserFormulation B
60% ethanol
20% i-propanol
1% myristyl alcohol
1% 1- (2-ethylhexyl) glycerol ether
ad 100% water
Die graphische Auftragung der erhaltenen Sebumeter-Werte (siehe Figur) verdeutlichen die überlegene durch den Glycerinether hervorgerufene rückfettende Wirkung besonders deutlich. Mit Formulierung B werden deutlich höhere Hautfettgehalte erreicht als mit Formulierung A, die bereits eine bekannte Rückfettungs komponente (Myristylalkohol) enthält. Der höhere Fettgehalt, der nach Anwendung von Formulierung B erhalten wird, nimmt zwar innerhalb einer Stunde nach erfolgter Anwendung deutlich ab, es verbleiben jedoch insbesondere nach mehrfacher Anwendung ein höherer Fettgehalt als nach Anwendung von Formulierung A.The graphic plot of the Sebumeter values obtained (see Figure) illustrate the superior by the glycerol ether particularly caused by the moisturizing effect. With Formulation B significantly higher skin fat levels are achieved as with Formulation A, which already has a known refatting component (myristyl alcohol). The higher fat content, the obtained after application of Formulation B, while taking within an hour of using it clearly off, it remain however in particular after multiple application a higher fat content than after application of Formulation A.
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19914140474 DE4140474C2 (en) | 1991-12-09 | 1991-12-09 | Skincare additive |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19914140474 DE4140474C2 (en) | 1991-12-09 | 1991-12-09 | Skincare additive |
Publications (2)
Publication Number | Publication Date |
---|---|
DE4140474A1 true DE4140474A1 (en) | 1993-06-17 |
DE4140474C2 DE4140474C2 (en) | 1995-07-13 |
Family
ID=6446575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19914140474 Expired - Lifetime DE4140474C2 (en) | 1991-12-09 | 1991-12-09 | Skincare additive |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE4140474C2 (en) |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995014073A1 (en) * | 1993-11-18 | 1995-05-26 | Henkel Kommanditgesellschaft Auf Aktien | Glyceric octyl ethers in surface-active mixtures |
FR2729050A1 (en) * | 1995-02-23 | 1996-07-12 | Oreal | Synergistic compsn. with microbicidal properties |
FR2734158A1 (en) * | 1995-05-17 | 1996-11-22 | Roche Posay Lab Pharma | ASSOCIATION OF A COMPOUND WITH ANTI-MICROBIAL ACTIVITY AND A GLYCEROL MONOALKYLETHER |
FR2755852A1 (en) * | 1996-11-15 | 1998-05-22 | Oreal | USE OF GLYCEROL ALKYLETHER IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AS ACTIVE FOR THE TREATMENT OF SEBORRHEA AND ACNE |
FR2767697A1 (en) * | 1997-09-01 | 1999-03-05 | Boots Co Plc | DERMATOLOGICAL COMPOSITION FOR PREVENTING THE DEVELOPMENT OF SYMPTOMS OF HYPERSENSITIVITY AND CUTANEOUS INTOLERANCE |
EP0926231A1 (en) * | 1997-12-26 | 1999-06-30 | Kao Corporation | Liquid detergent composition and use thereof |
WO2000000164A1 (en) * | 1998-06-29 | 2000-01-06 | The Procter & Gamble Company | Leave-on hair compositions which contain a diol |
EP1013754A1 (en) * | 1998-12-25 | 2000-06-28 | Kao Corporation | Detergent composition |
DE10025123A1 (en) * | 2000-05-20 | 2001-11-22 | Beiersdorf Ag | Deodorizing preparations with mono and oligoglycerol monocarboxylic acid monoesters, aryl compounds and glyceryl ethers |
DE10025122A1 (en) * | 2000-05-20 | 2001-11-22 | Beiersdorf Ag | Combinations of Clycerol monoalkyl ethers and fatty acid glycerides |
DE10028638A1 (en) * | 2000-06-09 | 2001-12-20 | Schuelke & Mayr Gmbh | Storage-stable composition useful in cosmetic and pharmaceutical compositions comprises combination of glycerol monoalkyl ether with antioxidant |
US6417146B1 (en) | 1999-10-12 | 2002-07-09 | Kao Corporation | Aqueous liquid detergent compositions having a surfactant, fatty acid glycol ester and a glyceryl ether |
WO2003032931A1 (en) * | 2001-10-13 | 2003-04-24 | Cognis Deutschland Gmbh & Co. Kg | Cosmetic and/or pharmaceutical preparations |
EP1369471A1 (en) * | 2002-06-05 | 2003-12-10 | Air Liquide Santé (International) | Glyceryl ethers as preservatives for cooling lubricants |
WO2004073666A1 (en) * | 2003-02-21 | 2004-09-02 | Beiersdorf Ag | Foamable cosmetic cleansing preparation |
US6846846B2 (en) | 2001-10-23 | 2005-01-25 | The Trustees Of Columbia University In The City Of New York | Gentle-acting skin disinfectants |
JP2008037844A (en) * | 2006-08-10 | 2008-02-21 | Shiseido Co Ltd | Method for producing powdery cosmetic |
EP1992327A1 (en) * | 2007-04-16 | 2008-11-19 | Air Liquide Santé (International) | Composition based on glycerol ether/polyol mixtures |
FR2923159A1 (en) * | 2007-11-07 | 2009-05-08 | Oreal | Use of glycerol monoalkyl ether e.g. as antioxidant/antiradical agents, to prevent/reduce effect of oxidative stress/free radical on the skin and/or integuments and as agent to fight against skin aging |
US7879365B2 (en) | 2002-02-07 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of dermal and mucosal irritation |
WO2012175399A1 (en) * | 2011-06-22 | 2012-12-27 | Henkel Ag & Co. Kgaa | Washing or cleaning agent having increased cleaning performance |
US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US9883671B2 (en) | 2012-07-13 | 2018-02-06 | L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Mixture of natural or nature-identical alcohols with improved effectiveness |
US9981069B2 (en) | 2007-06-20 | 2018-05-29 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10350166B2 (en) | 2009-07-29 | 2019-07-16 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US7329412B2 (en) | 2000-12-22 | 2008-02-12 | The Trustees Of Columbia University In The City Of New York | Antimicrobial medical devices containing chlorhexidine free base and salt |
DE10163838A1 (en) * | 2001-12-22 | 2003-07-03 | Beiersdorf Ag | Active ingredient combinations based on dialkyl-substituted acetic acids and glyceryl alkyl ethers that are effective against bacteria, Mycota and viruses |
US7745425B2 (en) | 2002-02-07 | 2010-06-29 | The Trustees Of Columbia University In The City Of New York | Non-irritating compositions containing zinc salts |
CA2475224C (en) | 2002-02-07 | 2011-11-01 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides |
DE10224979B4 (en) * | 2002-06-05 | 2004-07-15 | Schülke & Mayr GmbH | Use of synergistic preparations based on mixtures of glycerol ether with aromatic alcohol to combat mycobacteria |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
BRPI0412675A (en) | 2003-07-17 | 2006-10-03 | Univ Columbia | antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and / or constituents |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US7759327B2 (en) | 2006-01-06 | 2010-07-20 | The Trustees Of Columbia University In The City Of New York | Compositions containing zinc salts for coating medical articles |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
CA2712120A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
US8933134B2 (en) | 2010-06-09 | 2015-01-13 | L'oreal | Compositions containing agar and a softening agent |
-
1991
- 1991-12-09 DE DE19914140474 patent/DE4140474C2/en not_active Expired - Lifetime
Non-Patent Citations (2)
Title |
---|
JP 30 14 505 A, Derwent Abstr. 91-067928 [10] * |
JP 5 51 27 133 A, Derwent Abstr. 80-81608c [46] * |
Cited By (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995014073A1 (en) * | 1993-11-18 | 1995-05-26 | Henkel Kommanditgesellschaft Auf Aktien | Glyceric octyl ethers in surface-active mixtures |
FR2729050A1 (en) * | 1995-02-23 | 1996-07-12 | Oreal | Synergistic compsn. with microbicidal properties |
FR2734158A1 (en) * | 1995-05-17 | 1996-11-22 | Roche Posay Lab Pharma | ASSOCIATION OF A COMPOUND WITH ANTI-MICROBIAL ACTIVITY AND A GLYCEROL MONOALKYLETHER |
EP0747047A1 (en) * | 1995-05-17 | 1996-12-11 | LA ROCHE POSAY Laboratoire Pharmaceutique | Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent |
US5736574A (en) * | 1995-05-17 | 1998-04-07 | La Roche Posay Laboratoire Pharmaceutique | Pharmacceutical/cosmetic compositions comprising synergistic antimicrobial admixture |
US6040347A (en) * | 1996-11-15 | 2000-03-21 | Societe L'oreal S.A. | Treatment of seborrhoea/cutaneous disorders with octoxyglycerol |
FR2755852A1 (en) * | 1996-11-15 | 1998-05-22 | Oreal | USE OF GLYCEROL ALKYLETHER IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AS ACTIVE FOR THE TREATMENT OF SEBORRHEA AND ACNE |
WO1998022081A1 (en) * | 1996-11-15 | 1998-05-28 | L'oreal | Use of octoxyglycerin in a cosmetic and/or dermatological composition as active agent for the treatment of seborrhoea and/or acne |
WO1999011237A1 (en) * | 1997-09-01 | 1999-03-11 | The Boots Company Plc | Dermatological compositions |
FR2767697A1 (en) * | 1997-09-01 | 1999-03-05 | Boots Co Plc | DERMATOLOGICAL COMPOSITION FOR PREVENTING THE DEVELOPMENT OF SYMPTOMS OF HYPERSENSITIVITY AND CUTANEOUS INTOLERANCE |
EP0926231A1 (en) * | 1997-12-26 | 1999-06-30 | Kao Corporation | Liquid detergent composition and use thereof |
WO2000000164A1 (en) * | 1998-06-29 | 2000-01-06 | The Procter & Gamble Company | Leave-on hair compositions which contain a diol |
EP1013754A1 (en) * | 1998-12-25 | 2000-06-28 | Kao Corporation | Detergent composition |
US6221816B1 (en) | 1998-12-25 | 2001-04-24 | Kao Corporation | Detergent composition comprising a monoglyceryl ether |
CN1329018C (en) * | 1998-12-25 | 2007-08-01 | 花王株式会社 | Detergent composition |
US6417146B1 (en) | 1999-10-12 | 2002-07-09 | Kao Corporation | Aqueous liquid detergent compositions having a surfactant, fatty acid glycol ester and a glyceryl ether |
DE10025123A1 (en) * | 2000-05-20 | 2001-11-22 | Beiersdorf Ag | Deodorizing preparations with mono and oligoglycerol monocarboxylic acid monoesters, aryl compounds and glyceryl ethers |
DE10025123B4 (en) * | 2000-05-20 | 2014-07-10 | Beiersdorf Ag | Deodorizing preparations with oligoglycerol monocarboxylic acid monoesters, aryl compounds and glyceryl ethers |
EP1157685A2 (en) * | 2000-05-20 | 2001-11-28 | Beiersdorf AG | Deodorizing preparations containing mono- und oligoglycerine carboxylic acid esters, aryl compounds and glyceryl ethers |
EP1157686A2 (en) * | 2000-05-20 | 2001-11-28 | Beiersdorf Aktiengesellschaft | Combinations of glycerine-monoalkyl ethers and fatty acid glycerides |
DE10025122A1 (en) * | 2000-05-20 | 2001-11-22 | Beiersdorf Ag | Combinations of Clycerol monoalkyl ethers and fatty acid glycerides |
EP1157686A3 (en) * | 2000-05-20 | 2003-11-26 | Beiersdorf Aktiengesellschaft | Combinations of glycerine-monoalkyl ethers and fatty acid glycerides |
EP1157685A3 (en) * | 2000-05-20 | 2003-11-26 | Beiersdorf AG | Deodorizing preparations containing mono- und oligoglycerine carboxylic acid esters, aryl compounds and glyceryl ethers |
US6956062B2 (en) | 2000-06-09 | 2005-10-18 | Air Liquide Santé (International) | Storage-stable compositions of glycerol monoalkyl ethers |
DE10028638A1 (en) * | 2000-06-09 | 2001-12-20 | Schuelke & Mayr Gmbh | Storage-stable composition useful in cosmetic and pharmaceutical compositions comprises combination of glycerol monoalkyl ether with antioxidant |
US8592489B2 (en) | 2000-06-09 | 2013-11-26 | Air Liquide Sante (International) | Storage-stable compositions of glycerol monoalkyl ethers |
EP2279778A1 (en) | 2000-06-09 | 2011-02-02 | Air Liquide Santé (International) | Storage-stable compositions of glycerol monoalkyl ethers |
WO2003032931A1 (en) * | 2001-10-13 | 2003-04-24 | Cognis Deutschland Gmbh & Co. Kg | Cosmetic and/or pharmaceutical preparations |
US6846846B2 (en) | 2001-10-23 | 2005-01-25 | The Trustees Of Columbia University In The City Of New York | Gentle-acting skin disinfectants |
US7879365B2 (en) | 2002-02-07 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of dermal and mucosal irritation |
US8728998B2 (en) | 2002-06-05 | 2014-05-20 | Air Liquide Sante (International) | Glyceryl ethers as preservatives for cooling lubricants |
EP1369471A1 (en) * | 2002-06-05 | 2003-12-10 | Air Liquide Santé (International) | Glyceryl ethers as preservatives for cooling lubricants |
US7846885B2 (en) | 2002-06-05 | 2010-12-07 | Air Liquide Sante (International) | Glyceryl ethers as preservatives for cooling lubricants |
US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US11033491B2 (en) | 2002-10-25 | 2021-06-15 | Vyne Therapeutics Inc. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
WO2004073666A1 (en) * | 2003-02-21 | 2004-09-02 | Beiersdorf Ag | Foamable cosmetic cleansing preparation |
US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
JP2008037844A (en) * | 2006-08-10 | 2008-02-21 | Shiseido Co Ltd | Method for producing powdery cosmetic |
US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8093193B2 (en) | 2007-04-16 | 2012-01-10 | Air Liquide Sante (International) | Composition based on glycerol ether/polyol mixtures |
US8058218B2 (en) | 2007-04-16 | 2011-11-15 | Air Liquide Sante (International) | Composition based on glycerol ether/polyol mixtures |
EP2316410A3 (en) * | 2007-04-16 | 2011-06-22 | Air Liquide Santé (International) | Composition based on glycerol ether/polyol mixtures |
EP1992327A1 (en) * | 2007-04-16 | 2008-11-19 | Air Liquide Santé (International) | Composition based on glycerol ether/polyol mixtures |
US9981069B2 (en) | 2007-06-20 | 2018-05-29 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US10369102B2 (en) | 2007-08-07 | 2019-08-06 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US11103454B2 (en) | 2007-08-07 | 2021-08-31 | Vyne Therapeutics Inc. | Wax foamable vehicle and pharmaceutical compositions thereof |
FR2923159A1 (en) * | 2007-11-07 | 2009-05-08 | Oreal | Use of glycerol monoalkyl ether e.g. as antioxidant/antiradical agents, to prevent/reduce effect of oxidative stress/free radical on the skin and/or integuments and as agent to fight against skin aging |
US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
US11433025B2 (en) | 2007-12-07 | 2022-09-06 | Vyne Therapeutics Inc. | Oil foamable carriers and formulations |
US10213384B2 (en) | 2009-04-28 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10588858B2 (en) | 2009-04-28 | 2020-03-17 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10363216B2 (en) | 2009-04-28 | 2019-07-30 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10350166B2 (en) | 2009-07-29 | 2019-07-16 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US11219631B2 (en) | 2009-07-29 | 2022-01-11 | Vyne Pharmaceuticals Inc. | Foamable compositions, breakable foams and their uses |
US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
US10463742B2 (en) | 2009-10-02 | 2019-11-05 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10086080B2 (en) | 2009-10-02 | 2018-10-02 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
US10265404B2 (en) | 2009-10-02 | 2019-04-23 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US10137200B2 (en) | 2009-10-02 | 2018-11-27 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10238746B2 (en) | 2009-10-02 | 2019-03-26 | Foamix Pharmaceuticals Ltd | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10517882B2 (en) | 2009-10-02 | 2019-12-31 | Foamix Pharmaceuticals Ltd. | Method for healing of an infected acne lesion without scarring |
US10213512B2 (en) | 2009-10-02 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10610599B2 (en) | 2009-10-02 | 2020-04-07 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10821187B2 (en) | 2009-10-02 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US10322186B2 (en) | 2009-10-02 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10835613B2 (en) | 2009-10-02 | 2020-11-17 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US10946101B2 (en) | 2009-10-02 | 2021-03-16 | Vyne Therapeutics Inc. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10967063B2 (en) | 2009-10-02 | 2021-04-06 | Vyne Therapeutics Inc. | Surfactant-free, water-free formable composition and breakable foams and their uses |
WO2012175399A1 (en) * | 2011-06-22 | 2012-12-27 | Henkel Ag & Co. Kgaa | Washing or cleaning agent having increased cleaning performance |
US9883671B2 (en) | 2012-07-13 | 2018-02-06 | L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Mixture of natural or nature-identical alcohols with improved effectiveness |
US10849847B2 (en) | 2016-09-08 | 2020-12-01 | Foamix Pharamaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US11324691B2 (en) | 2016-09-08 | 2022-05-10 | Journey Medical Corporation | Compositions and methods for treating rosacea and acne |
Also Published As
Publication number | Publication date |
---|---|
DE4140474C2 (en) | 1995-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE4140474C2 (en) | Skincare additive | |
DE69912133T2 (en) | FOAMING OIL COMPOSITION AND ITS USE | |
EP2902010B1 (en) | Aqueous tenside compositions | |
DE3018598A1 (en) | REMOVAL PRODUCT FOR THE FACE AND EYES | |
DE1816927A1 (en) | Liquid products for the treatment of natural or synthetic fibers | |
DE2700891C2 (en) | ||
EP0047916B2 (en) | Body cleansing agent | |
DE3522853A1 (en) | HAIR COSMETIC COMPOSITION | |
EP0499700A1 (en) | Mixture of fatty acid esters of polyglycerine | |
WO1996014374A1 (en) | Solubilizer-containing surfactants | |
DE1617727B2 (en) | CLEAR, NON-Aqueous, LIQUID COMPOSITION BASED ON MINERAL OIL AND FATTY ACID ESTERS | |
DE4301994C1 (en) | Hair and body cleansers | |
DE3732838A1 (en) | COMPOSITION FOR CLEANING THE SKIN IN THE FORM OF A ROD OR PEN | |
DE1201951B (en) | Stable acidic main care emulsion | |
EP0641377B1 (en) | Mild surfactant mixture | |
EP0120224B1 (en) | Functional oil cream bath | |
DE69728934T2 (en) | Use of 3-iodo-2-propynyl butyl carbamate in a cosmetic and / or dermatological composition as an active ingredient for the treatment of seborrhoea | |
EP3464532B1 (en) | Aqueous surfactant compositions | |
EP3458024B1 (en) | Aqueous tenside compositions | |
DE3837985A1 (en) | Acidic hair and body cleanser | |
DE4111807A1 (en) | FATTY ACID MONOGLYCERID POLYGLYCOLETHERSULFOSUCCI NATE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE | |
DE3590272T (en) | Vegetable oil extracts as emollients in skin and hair care products | |
EP3272328A1 (en) | Aqueous tenside compositions | |
DE3825536A1 (en) | USE OF HYDROPOXES FOR THE TREATMENT OF ACNE AND SEBORRHOE | |
DE19904847A1 (en) | Oil-in-water microemulsion containing alkanolammonium salts of the alkyl sulfates and / or alkyl polyalkylene glycol ether sulfates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: SCHUELKE & MAYR GMBH, 20354 HAMBURG, DE |
|
R071 | Expiry of right | ||
R071 | Expiry of right |